Treatment-related fluctuations in subacute inflammatory demyelinating polyneuropathyChronic inflammatory demyelinating polyneuropathyGuillain-Barre syndromeSubacute inflammatory demyelinating polyneuropathyTreatment-related fluctuationTreatment-related fluctuation (TRF), only defined in Guillain-Barre syndrome (GBS), refer ...
Treatment related fluctuations in Guillain-Barré syndrome after high-dose immunoglobulins or plasma-exchange. Since the introduction of plasma exchange as a treatment for Guillain-Barr茅 syndrome (GBS) patients, treatment related fluctuations have been found to occ... RP Kleyweg,dMFG Van - 《Journa...
A. Distinguishing acute-onset CIDP from Guillain–Barré syndrome with treatment related fluctuations. Neurology 65, 138–140 (2005). Article PubMed Google Scholar Ruts, L., Drenthen, J., Jacobs, B. C. & van Doorn, P. A; Dutch GBS Study Group. Distinguishing acute-onset CIDP from ...
Corticosteroids, intravenous immunoglobulin (IVIg) and plasmapheresis provide short-term benefits; IVIg is used for long-term maintenance Potential new therapeutic approaches involve targeting key factors in the immunopathogenesis of CIDP, including T cells, B cells and complement Progress in clinical trial...
Treatment related fluctuations (TRFs) in Guillain-Barr茅 Syndrome (GBS) are described as one or more episodes of deterioration manifesting within two months after disease onset and following an initial improvement or stabilisation after treatment. They may be encountered in 8% to 16% of patients, ...
Distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy (A-CIDP) from GuillainBarré syndrome (GBS) with treatment-related fluctuations (TRF) in the early phase of disease can be challenging. Although characteristic clinical features have been previously reported, there is limited data ...
Distinguishing acute-onset CIDP from Guillain-Barré syndrome with treatment related fluctuations. Neurology 2005; 65 - Ruts, Koningsveld, et al. () Citation Context ...up to 16% of all patients with CIDP. Acute-onset CIDP in a patient initially diagnosed as GBS is likely if deterioration...
CSF albumino-cytologic dissociation was present in 43%. Electrodiagnostic testing most frequently demonstrated demyelination (64%). 98% received immunotherapy, mostly IVIg (93%). 22% received further treatment due to treatment-related fluctuations or lack of improvement. 13% required ICU admission ...